GynePro Competitors

Natera™ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women’s health, organ health, and rare disease. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 325 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California, and through Foresight Diagnostics, its subsidiary, operates an ISO 27001-certified and CAP-accredited laboratory certified under CLIA in Boulder, Colorado. Please be advised that Natera will only reach out to candidates with an @natera.com email domain. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes. https://www.natera.com/privacy/

CareFusion, a BD company, is a global corporation serving the health care industry with products and services that help improve the cost and safety of health care for generations to come. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife™ and LTV® series ventilation and respiratory products, ChloraPrep® skin preparation products, MedMined™ services for data mining surveillance, V. Mueller® surgical instruments and an extensive line of products that support interventional medicine. In March 2015, CareFusion joined Becton Dickinson to form a global leader in medication management and patient safety solutions.

Cranial Technologies® is the leading global provider for the treatment of infants with plagiocephaly (flat head syndrome). For over 35 years we have focused on developing the science, the products, and the therapy for treating pediatric head shape condition. With over 125 clinics in the U.S. and Europe, Cranial Technologies expert teams have successfully treated over 400,000 babies using our proprietary DOC Band® cranial orthotic helmet. We also provided corrective infant ear shaping therapy for ear deformities at select clinic, using the EarWell® Infant Ear Molding System. We provide compassionate, non-surgical treatment for flat heads, lop ears, prominent ears, and other ear conditions. Our mission is to continually advance our treatment experience to deliver exception outcomes for every family and baby we see.